Zealand Pharma A/S (0NZU.IL)
| Previous close | 799.25 |
| Open | 786.50 |
| Bid | 744.50 x 0 |
| Ask | 782.50 x 0 |
| Day's range | 752.50 - 788.50 |
| 52-week range | 276.00 - 969.00 |
| Volume | |
| Avg. volume | 50,656 |
| Market cap | 45.523B |
| Beta (5Y monthly) | 0.62 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Investing.com
Zealand Pharma rebound after prior session losses
Shares in Zealand Pharma (CSE:ZELA) rose on Tuesday, recovering losses from the previous session which came in the wake of comments by the company's CEO about seeking a large pharmaceutical partner for the company’s weight loss drug. At 5:02 am (0902 GMT), Zealand Pharma was trading 3.8% higher at DKK 943.50. Analysts at Jefferies have highlighted the company’s promising amylin pipeline and potential for lucrative partnerships as key drivers for the share price increase.
- Zacks
Here's What Could Help Zealand Pharma AS (ZLDPF) Maintain Its Recent Price Strength
If you are looking for stocks that are well positioned to maintain their recent uptrend, Zealand Pharma AS (ZLDPF) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
- Zacks
Strength Seen in Zealand Pharma AS (ZLDPF): Can Its 11.6% Jump Turn into More Strength?
Zealand Pharma AS (ZLDPF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
